<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04165577</url>
  </required_header>
  <id_info>
    <org_study_id>1901-003</org_study_id>
    <nct_id>NCT04165577</nct_id>
  </id_info>
  <brief_title>Modulating Prefrontal Circuits Underlying Behavioral Flexibility in OCD: A TMS Study</brief_title>
  <official_title>Modulating Prefrontal Circuits Underlying Behavioral Flexibility in OCD: A TMS Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Butler Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates whether slow-frequency repetitive transcranial magnetic stimulation
      targeting frontal pole can acutely modulate brain circuits which show abnormal functioning
      during behavioral flexibility in obsessive-compulsive disorder, as well as performance on a
      behavioral task.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2019</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in regional activation in orbitofrontal cortex</measure>
    <time_frame>Before rTMS and within 30 minutes immediately following rTMS</time_frame>
    <description>Change in task-based regional activation (assessed via functional magnetic resonance imaging; fMRI) in orbitofrontal cortex</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in regional activation in dorsolateral prefrontal cortex</measure>
    <time_frame>Before rTMS and within 30 minutes immediately following rTMS</time_frame>
    <description>Change in task-based regional activation (assessed via fMRI) in dorsolateral prefrontal cortex</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in regional activation in anterior cingulate cortex</measure>
    <time_frame>Before rTMS and within 30 minutes immediately following rTMS</time_frame>
    <description>Change in task-based regional activation (assessed via fMRI) in anterior cingulate cortex</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resting-state functional connectivity with ventral striatum</measure>
    <time_frame>Before rTMS and within 30 minutes immediately following rTMS</time_frame>
    <description>Resting-state functional connectivity with ventral striatum (assessed via fMRI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting-state functional connectivity with dorsal striatum</measure>
    <time_frame>Before rTMS and within 30 minutes immediately following rTMS</time_frame>
    <description>Resting-state functional connectivity with dorsal striatum (assessed via fMRI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive flexibility task performance</measure>
    <time_frame>Before rTMS and within 30 minutes immediately following rTMS</time_frame>
    <description>Behavioral performance on a cognitive flexibility task (% trials correct)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>OCD, Active TMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants with OCD who receive active rTMS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OCD, Sham TMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants with OCD who receive sham rTMS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control, Active TMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy control participants who receive active rTMS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control, Sham TMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy control participants who receive sham rTMS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <description>1-Hz rTMS targeting frontal pole</description>
    <arm_group_label>Healthy Control, Active TMS</arm_group_label>
    <arm_group_label>OCD, Active TMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham rTMS</intervention_name>
    <description>sham rTMS targeting frontal pole</description>
    <arm_group_label>Healthy Control, Sham TMS</arm_group_label>
    <arm_group_label>OCD, Sham TMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: OCD group

          -  current primary diagnosis of obsessive-compulsive disorder and Yale-Brown Obsessive
             Compulsive Scale total score â‰¥ 16;

          -  18-55 years of age;

          -  ability to speak, read, write, and understand English sufficiently well to complete
             study procedures and provide informed consent;

          -  either no use of psychiatric medication or stable psychiatric medication use for 6
             weeks prior to study entry, limited to use of serotonin reuptake inhibitors and PRN
             use of benzodiazepines (other psychiatric medication use excluded), and

          -  right-handed.

        Inclusion Criteria: Healthy Control group

          -  18-55 years of age;

          -  ability to speak, read, write, and understand English sufficiently well to complete
             study procedures and provide informed consent;

          -  right-handed.

        Exclusion Criteria: OCD group

          -  active problematic substance use;

          -  lifetime psychosis or bipolar mood disorder or OCD beliefs of delusional nature;

          -  clinically significant hoarding symptoms;

          -  active suicidal or homicidal ideation;

          -  significant neurological disease or intracranial pathology;

          -  use of medications which increase risk for seizures during TMS;

          -  significant or unstable medical disorders or contraindication to TMS or MRI scan.

        Exclusion Criteria: Healthy Control group

          -  current psychiatric diagnosis;

          -  lifetime psychosis, bipolar mood disorder, or OCD;

          -  active suicidal or homicidal ideation;

          -  significant neurological disease or intracranial pathology;

          -  use of psychiatric medications;

          -  use of medications which increase risk for seizures during TMS;

          -  significant or unstable medical disorders or contraindication to TMS or MRI scan.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Garnaat, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Butler Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Garnaat, PhD</last_name>
    <phone>401-455-6610</phone>
    <email>sgarnaat@butler.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Garnaat, PhD</last_name>
      <phone>401-455-6610</phone>
      <email>sgarnaat@butler.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2019</study_first_posted>
  <last_update_submitted>November 27, 2019</last_update_submitted>
  <last_update_submitted_qc>November 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

